Triple negative breast neoplasms Clinical Trials

Delta Trials catalogs 54 clinical trials for Triple negative breast neoplasms in its publicly accessible dataset. Within this set, 14 currently recruiting participants and 15 trials have reached completion. This research occurs across 846 participating sites around the world. An additional 25 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 14 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.